nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CASK—hair follicle—vitiligo	0.0119	0.0272	CbGeAlD
Bosutinib—EIF2AK1—hair follicle—vitiligo	0.0118	0.0269	CbGeAlD
Bosutinib—STK26—hair follicle—vitiligo	0.011	0.0251	CbGeAlD
Bosutinib—STK24—hair follicle—vitiligo	0.00911	0.0209	CbGeAlD
Bosutinib—PTK2—skin epidermis—vitiligo	0.00881	0.0202	CbGeAlD
Bosutinib—PKMYT1—neck—vitiligo	0.00836	0.0191	CbGeAlD
Bosutinib—STK3—hair follicle—vitiligo	0.00823	0.0189	CbGeAlD
Bosutinib—CDK2—neck—vitiligo	0.00742	0.017	CbGeAlD
Bosutinib—CSK—hair follicle—vitiligo	0.00729	0.0167	CbGeAlD
Bosutinib—CSNK1A1—hair follicle—vitiligo	0.00724	0.0166	CbGeAlD
Bosutinib—ERBB3—hair follicle—vitiligo	0.00648	0.0148	CbGeAlD
Bosutinib—IKBKE—thyroid gland—vitiligo	0.00633	0.0145	CbGeAlD
Bosutinib—TBK1—hair follicle—vitiligo	0.00628	0.0144	CbGeAlD
Bosutinib—IRAK1—hair follicle—vitiligo	0.00616	0.0141	CbGeAlD
Bosutinib—MAP4K5—hair follicle—vitiligo	0.00547	0.0125	CbGeAlD
Bosutinib—BMX—skin of body—vitiligo	0.00528	0.0121	CbGeAlD
Bosutinib—YES1—hair follicle—vitiligo	0.00505	0.0116	CbGeAlD
Bosutinib—MAP2K1—neck—vitiligo	0.00492	0.0113	CbGeAlD
Bosutinib—CSNK1A1—neck—vitiligo	0.00486	0.0111	CbGeAlD
Bosutinib—CLK1—neck—vitiligo	0.00483	0.0111	CbGeAlD
Bosutinib—CDK2—skin of body—vitiligo	0.0048	0.011	CbGeAlD
Bosutinib—BMP2K—neck—vitiligo	0.00474	0.0109	CbGeAlD
Bosutinib—PLK2—skin of body—vitiligo	0.00423	0.0097	CbGeAlD
Bosutinib—PTK2—neck—vitiligo	0.00422	0.00966	CbGeAlD
Bosutinib—TBK1—neck—vitiligo	0.00422	0.00966	CbGeAlD
Bosutinib—TLK1—thyroid gland—vitiligo	0.0042	0.00961	CbGeAlD
Bosutinib—PRKCQ—thyroid gland—vitiligo	0.00414	0.00948	CbGeAlD
Bosutinib—STK33—thyroid gland—vitiligo	0.00408	0.00935	CbGeAlD
Bosutinib—RPS6KB1—neck—vitiligo	0.00406	0.00929	CbGeAlD
Bosutinib—PKMYT1—thyroid gland—vitiligo	0.00398	0.00911	CbGeAlD
Bosutinib—STK24—skin of body—vitiligo	0.00395	0.00906	CbGeAlD
Bosutinib—DSTYK—thyroid gland—vitiligo	0.00388	0.00889	CbGeAlD
Bosutinib—BMX—thyroid gland—vitiligo	0.00388	0.00889	CbGeAlD
Bosutinib—CLK3—thyroid gland—vitiligo	0.00388	0.00889	CbGeAlD
Bosutinib—TYRO3—skin of body—vitiligo	0.00383	0.00877	CbGeAlD
Bosutinib—PHKG1—thyroid gland—vitiligo	0.00379	0.00869	CbGeAlD
Bosutinib—CASK—thyroid gland—vitiligo	0.00379	0.00869	CbGeAlD
Bosutinib—EIF2AK1—thyroid gland—vitiligo	0.00375	0.0086	CbGeAlD
Bosutinib—FES—thyroid gland—vitiligo	0.00364	0.00833	CbGeAlD
Bosutinib—VRK2—thyroid gland—vitiligo	0.00364	0.00833	CbGeAlD
Bosutinib—TNIK—thyroid gland—vitiligo	0.00357	0.00817	CbGeAlD
Bosutinib—SYK—thyroid gland—vitiligo	0.00357	0.00817	CbGeAlD
Bosutinib—CDK2—thyroid gland—vitiligo	0.00353	0.0081	CbGeAlD
Bosutinib—STK26—thyroid gland—vitiligo	0.0035	0.00802	CbGeAlD
Bosutinib—BMPR2—skin of body—vitiligo	0.00343	0.00785	CbGeAlD
Bosutinib—CHEK2—thyroid gland—vitiligo	0.00338	0.00775	CbGeAlD
Bosutinib—WEE1—thyroid gland—vitiligo	0.00335	0.00768	CbGeAlD
Bosutinib—DMPK—thyroid gland—vitiligo	0.00335	0.00768	CbGeAlD
Bosutinib—STK25—thyroid gland—vitiligo	0.0032	0.00734	CbGeAlD
Bosutinib—MAP2K1—skin of body—vitiligo	0.00319	0.0073	CbGeAlD
Bosutinib—STK35—skin of body—vitiligo	0.00319	0.0073	CbGeAlD
Bosutinib—EPHA3—thyroid gland—vitiligo	0.00318	0.00728	CbGeAlD
Bosutinib—CSK—skin of body—vitiligo	0.00317	0.00725	CbGeAlD
Bosutinib—CSNK1A1—skin of body—vitiligo	0.00315	0.00721	CbGeAlD
Bosutinib—PLK2—thyroid gland—vitiligo	0.00311	0.00713	CbGeAlD
Bosutinib—SIK3—thyroid gland—vitiligo	0.00309	0.00709	CbGeAlD
Bosutinib—STK4—thyroid gland—vitiligo	0.00298	0.00682	CbGeAlD
Bosutinib—CAMK1D—thyroid gland—vitiligo	0.00294	0.00674	CbGeAlD
Bosutinib—CSNK1E—skin of body—vitiligo	0.00291	0.00668	CbGeAlD
Bosutinib—STK24—thyroid gland—vitiligo	0.00291	0.00666	CbGeAlD
Bosutinib—SIK1—skin of body—vitiligo	0.00287	0.00657	CbGeAlD
Bosutinib—FER—thyroid gland—vitiligo	0.00281	0.00645	CbGeAlD
Bosutinib—ERBB3—skin of body—vitiligo	0.00281	0.00644	CbGeAlD
Bosutinib—MAP2K2—skin of body—vitiligo	0.00281	0.00643	CbGeAlD
Bosutinib—MAP4K1—thyroid gland—vitiligo	0.00276	0.00632	CbGeAlD
Bosutinib—BTK—thyroid gland—vitiligo	0.00274	0.00628	CbGeAlD
Bosutinib—PTK2—skin of body—vitiligo	0.00273	0.00625	CbGeAlD
Bosutinib—TNK2—thyroid gland—vitiligo	0.0027	0.00619	CbGeAlD
Bosutinib—MAP4K2—thyroid gland—vitiligo	0.00267	0.00611	CbGeAlD
Bosutinib—ERBB4—thyroid gland—vitiligo	0.00263	0.00602	CbGeAlD
Bosutinib—STK3—thyroid gland—vitiligo	0.00263	0.00602	CbGeAlD
Bosutinib—AXL—skin of body—vitiligo	0.0026	0.00595	CbGeAlD
Bosutinib—PDGFRB—neck—vitiligo	0.0026	0.00595	CbGeAlD
Bosutinib—BMPR2—thyroid gland—vitiligo	0.00252	0.00578	CbGeAlD
Bosutinib—STK36—thyroid gland—vitiligo	0.0025	0.00573	CbGeAlD
Bosutinib—MERTK—thyroid gland—vitiligo	0.00247	0.00566	CbGeAlD
Bosutinib—FYN—skin of body—vitiligo	0.00243	0.00557	CbGeAlD
Bosutinib—MAP4K4—thyroid gland—vitiligo	0.00243	0.00556	CbGeAlD
Bosutinib—NUAK2—thyroid gland—vitiligo	0.00241	0.00552	CbGeAlD
Bosutinib—BCR—thyroid gland—vitiligo	0.00241	0.00552	CbGeAlD
Bosutinib—MAP3K12—thyroid gland—vitiligo	0.00239	0.00548	CbGeAlD
Bosutinib—MAP3K3—skin of body—vitiligo	0.00238	0.00544	CbGeAlD
Bosutinib—STK35—thyroid gland—vitiligo	0.00234	0.00537	CbGeAlD
Bosutinib—CSK—thyroid gland—vitiligo	0.00233	0.00533	CbGeAlD
Bosutinib—CSNK1A1—thyroid gland—vitiligo	0.00231	0.0053	CbGeAlD
Bosutinib—HCK—thyroid gland—vitiligo	0.0023	0.00527	CbGeAlD
Bosutinib—CLK1—thyroid gland—vitiligo	0.0023	0.00527	CbGeAlD
Bosutinib—ABL2—thyroid gland—vitiligo	0.00228	0.00523	CbGeAlD
Bosutinib—CAMK2G—thyroid gland—vitiligo	0.00226	0.00517	CbGeAlD
Bosutinib—BMP2K—thyroid gland—vitiligo	0.00226	0.00517	CbGeAlD
Bosutinib—LRRK2—thyroid gland—vitiligo	0.00224	0.00512	CbGeAlD
Bosutinib—EGFR—thyroid gland—vitiligo	0.00223	0.00511	CbGeAlD
Bosutinib—PTK2B—thyroid gland—vitiligo	0.00218	0.00499	CbGeAlD
Bosutinib—CSNK1E—thyroid gland—vitiligo	0.00214	0.00491	CbGeAlD
Bosutinib—SRC—skin of body—vitiligo	0.00211	0.00484	CbGeAlD
Bosutinib—SIK1—thyroid gland—vitiligo	0.00211	0.00484	CbGeAlD
Bosutinib—IRAK4—thyroid gland—vitiligo	0.00211	0.00484	CbGeAlD
Bosutinib—EPHA4—thyroid gland—vitiligo	0.00209	0.00479	CbGeAlD
Bosutinib—ERBB3—thyroid gland—vitiligo	0.00207	0.00474	CbGeAlD
Bosutinib—ULK3—thyroid gland—vitiligo	0.00206	0.00473	CbGeAlD
Bosutinib—MAP2K2—thyroid gland—vitiligo	0.00206	0.00473	CbGeAlD
Bosutinib—MAP3K2—thyroid gland—vitiligo	0.00205	0.00469	CbGeAlD
Bosutinib—MAP3K7—thyroid gland—vitiligo	0.00203	0.00465	CbGeAlD
Bosutinib—TBK1—thyroid gland—vitiligo	0.00201	0.0046	CbGeAlD
Bosutinib—PTK2—thyroid gland—vitiligo	0.00201	0.0046	CbGeAlD
Bosutinib—IRAK1—thyroid gland—vitiligo	0.00197	0.00451	CbGeAlD
Bosutinib—RPS6KB1—thyroid gland—vitiligo	0.00193	0.00442	CbGeAlD
Bosutinib—FGR—thyroid gland—vitiligo	0.00192	0.0044	CbGeAlD
Bosutinib—LCK—thyroid gland—vitiligo	0.00192	0.0044	CbGeAlD
Bosutinib—AXL—thyroid gland—vitiligo	0.00191	0.00438	CbGeAlD
Bosutinib—CSF1R—skin of body—vitiligo	0.0019	0.00434	CbGeAlD
Bosutinib—SLK—thyroid gland—vitiligo	0.00184	0.00421	CbGeAlD
Bosutinib—EPHB4—thyroid gland—vitiligo	0.00183	0.00418	CbGeAlD
Bosutinib—EPHA2—thyroid gland—vitiligo	0.00179	0.0041	CbGeAlD
Bosutinib—FYN—thyroid gland—vitiligo	0.00179	0.0041	CbGeAlD
Bosutinib—MAP4K5—thyroid gland—vitiligo	0.00175	0.004	CbGeAlD
Bosutinib—MAP3K3—thyroid gland—vitiligo	0.00175	0.004	CbGeAlD
Bosutinib—PDGFRB—skin of body—vitiligo	0.00168	0.00385	CbGeAlD
Bosutinib—YES1—thyroid gland—vitiligo	0.00161	0.0037	CbGeAlD
Bosutinib—STK10—thyroid gland—vitiligo	0.0016	0.00366	CbGeAlD
Bosutinib—TAOK3—thyroid gland—vitiligo	0.00159	0.00365	CbGeAlD
Bosutinib—SRC—thyroid gland—vitiligo	0.00155	0.00356	CbGeAlD
Bosutinib—ABL1—skin of body—vitiligo	0.0015	0.00343	CbGeAlD
Bosutinib—MAP2K5—thyroid gland—vitiligo	0.00143	0.00327	CbGeAlD
Bosutinib—CSF1R—thyroid gland—vitiligo	0.00139	0.00319	CbGeAlD
Bosutinib—PDGFRB—thyroid gland—vitiligo	0.00124	0.00283	CbGeAlD
Bosutinib—ABL1—thyroid gland—vitiligo	0.0011	0.00252	CbGeAlD
Bosutinib—ABCB1—thyroid gland—vitiligo	0.000343	0.000785	CbGeAlD
Bosutinib—PDGFRB—Adaptive Immune System—CD8A—vitiligo	6.47e-05	0.000115	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IFIH1—vitiligo	6.46e-05	0.000115	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CCR6—vitiligo	6.46e-05	0.000115	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD44—vitiligo	6.45e-05	0.000114	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD8A—vitiligo	6.41e-05	0.000114	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SH2B3—vitiligo	6.41e-05	0.000114	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SH2B3—vitiligo	6.41e-05	0.000114	CbGpPWpGaD
Bosutinib—CSK—Disease—CD80—vitiligo	6.4e-05	0.000114	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—CD80—vitiligo	6.39e-05	0.000113	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD8A—vitiligo	6.39e-05	0.000113	CbGpPWpGaD
Bosutinib—HCK—Immune System—IL2RA—vitiligo	6.37e-05	0.000113	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—GZMB—vitiligo	6.37e-05	0.000113	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—GZMB—vitiligo	6.37e-05	0.000113	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—CD80—vitiligo	6.36e-05	0.000113	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CTLA4—vitiligo	6.36e-05	0.000113	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD8A—vitiligo	6.34e-05	0.000112	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—CD80—vitiligo	6.32e-05	0.000112	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—CD80—vitiligo	6.32e-05	0.000112	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD8A—vitiligo	6.24e-05	0.000111	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—IL2RA—vitiligo	6.24e-05	0.000111	CbGpPWpGaD
Bosutinib—TBK1—Immune System—CD80—vitiligo	6.22e-05	0.00011	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SH2B3—vitiligo	6.18e-05	0.00011	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CCR6—vitiligo	6.14e-05	0.000109	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—GZMB—vitiligo	6.14e-05	0.000109	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—CD80—vitiligo	6.1e-05	0.000108	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD44—vitiligo	6.07e-05	0.000108	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—IL2RA—vitiligo	6e-05	0.000107	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CTLA4—vitiligo	5.99e-05	0.000106	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CTLA4—vitiligo	5.98e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MC1R—vitiligo	5.98e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—CD80—vitiligo	5.96e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—CD80—vitiligo	5.95e-05	0.000106	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—IL2RA—vitiligo	5.92e-05	0.000105	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD8A—vitiligo	5.87e-05	0.000104	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MC1R—vitiligo	5.83e-05	0.000103	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CCR6—vitiligo	5.8e-05	0.000103	CbGpPWpGaD
Bosutinib—BTK—Immune System—CD80—vitiligo	5.8e-05	0.000103	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL2RA—vitiligo	5.78e-05	0.000103	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL2RA—vitiligo	5.76e-05	0.000102	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CCR6—vitiligo	5.72e-05	0.000101	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—CD80—vitiligo	5.71e-05	0.000101	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MC1R—vitiligo	5.71e-05	0.000101	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL2RA—vitiligo	5.66e-05	0.000101	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MC1R—vitiligo	5.62e-05	9.98e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IFIH1—vitiligo	5.61e-05	9.96e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CCR6—vitiligo	5.61e-05	9.96e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MC1R—vitiligo	5.59e-05	9.92e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL2RA—vitiligo	5.56e-05	9.87e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL2RA—vitiligo	5.56e-05	9.87e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—CD80—vitiligo	5.56e-05	9.87e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—CD80—vitiligo	5.54e-05	9.83e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SH2B3—vitiligo	5.5e-05	9.76e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—GZMB—vitiligo	5.46e-05	9.7e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CCR6—vitiligo	5.42e-05	9.63e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SH2B3—vitiligo	5.42e-05	9.62e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—IL2RA—vitiligo	5.42e-05	9.61e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFIH1—vitiligo	5.41e-05	9.59e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CCR6—vitiligo	5.41e-05	9.59e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD8A—vitiligo	5.39e-05	9.57e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—GZMB—vitiligo	5.39e-05	9.56e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL2RA—vitiligo	5.37e-05	9.53e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—CD80—vitiligo	5.35e-05	9.5e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—CD80—vitiligo	5.32e-05	9.44e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD44—vitiligo	5.31e-05	9.42e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL2RA—vitiligo	5.29e-05	9.39e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CTLA4—vitiligo	5.23e-05	9.28e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD8A—vitiligo	5.23e-05	9.28e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CD80—vitiligo	5.2e-05	9.22e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD8A—vitiligo	5.19e-05	9.22e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD44—vitiligo	5.18e-05	9.19e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD8A—vitiligo	5.16e-05	9.15e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SH2B3—vitiligo	5.14e-05	9.13e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—GZMB—vitiligo	5.11e-05	9.07e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CCR6—vitiligo	5.11e-05	9.06e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CTLA4—vitiligo	5.11e-05	9.06e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD44—vitiligo	5.07e-05	9e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CD80—vitiligo	5.07e-05	9e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD44—vitiligo	5.05e-05	8.96e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD80—vitiligo	5.01e-05	8.89e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CTLA4—vitiligo	5e-05	8.87e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD44—vitiligo	4.99e-05	8.86e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CTLA4—vitiligo	4.98e-05	8.83e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD44—vitiligo	4.97e-05	8.81e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CD80—vitiligo	4.97e-05	8.81e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CD80—vitiligo	4.94e-05	8.77e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD80—vitiligo	4.94e-05	8.77e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CTLA4—vitiligo	4.92e-05	8.73e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—CD80—vitiligo	4.91e-05	8.72e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD44—vitiligo	4.9e-05	8.7e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CTLA4—vitiligo	4.9e-05	8.69e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD8A—vitiligo	4.89e-05	8.68e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CD80—vitiligo	4.89e-05	8.67e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD80—vitiligo	4.87e-05	8.64e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CD80—vitiligo	4.86e-05	8.63e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MC1R—vitiligo	4.86e-05	8.62e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SH2B3—vitiligo	4.84e-05	8.59e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD80—vitiligo	4.82e-05	8.56e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—GZMB—vitiligo	4.81e-05	8.54e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD80—vitiligo	4.8e-05	8.53e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—IL2RA—vitiligo	4.79e-05	8.51e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFIH1—vitiligo	4.79e-05	8.49e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CCR6—vitiligo	4.79e-05	8.49e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD44—vitiligo	4.78e-05	8.49e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD80—vitiligo	4.77e-05	8.46e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CD80—vitiligo	4.73e-05	8.39e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL2RA—vitiligo	4.71e-05	8.36e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD80—vitiligo	4.69e-05	8.33e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MC1R—vitiligo	4.68e-05	8.3e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—GSTM1—vitiligo	4.65e-05	8.25e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL2RA—vitiligo	4.65e-05	8.25e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CD80—vitiligo	4.64e-05	8.23e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CD80—vitiligo	4.64e-05	8.23e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CD80—vitiligo	4.63e-05	8.21e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD44—vitiligo	4.61e-05	8.18e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD8A—vitiligo	4.6e-05	8.17e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD8A—vitiligo	4.6e-05	8.16e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD44—vitiligo	4.59e-05	8.14e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	4.59e-05	8.14e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL2RA—vitiligo	4.49e-05	7.97e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CD80—vitiligo	4.48e-05	7.95e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCR6—vitiligo	4.46e-05	7.92e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD80—vitiligo	4.42e-05	7.84e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL2RA—vitiligo	4.41e-05	7.82e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCR6—vitiligo	4.36e-05	7.73e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD44—vitiligo	4.31e-05	7.66e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCR6—vitiligo	4.26e-05	7.57e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CTLA4—vitiligo	4.25e-05	7.55e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SH2B3—vitiligo	4.23e-05	7.51e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CD80—vitiligo	4.22e-05	7.49e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—GZMB—vitiligo	4.21e-05	7.46e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCR6—vitiligo	4.2e-05	7.45e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCR6—vitiligo	4.18e-05	7.41e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD44—vitiligo	4.16e-05	7.38e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL2RA—vitiligo	4.15e-05	7.36e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MC1R—vitiligo	4.14e-05	7.35e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SH2B3—vitiligo	4.13e-05	7.33e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—GZMB—vitiligo	4.1e-05	7.28e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CTLA4—vitiligo	4.1e-05	7.27e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CD80—vitiligo	4.08e-05	7.24e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CD80—vitiligo	4.07e-05	7.22e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD80—vitiligo	4.06e-05	7.2e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SH2B3—vitiligo	4.04e-05	7.17e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD8A—vitiligo	4.02e-05	7.14e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—GZMB—vitiligo	4.02e-05	7.13e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD44—vitiligo	3.98e-05	7.07e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SH2B3—vitiligo	3.98e-05	7.06e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL2RA—vitiligo	3.97e-05	7.04e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SH2B3—vitiligo	3.96e-05	7.03e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—GZMB—vitiligo	3.96e-05	7.02e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—GZMB—vitiligo	3.93e-05	6.98e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD80—vitiligo	3.93e-05	6.98e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD8A—vitiligo	3.93e-05	6.97e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD80—vitiligo	3.91e-05	6.93e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL2RA—vitiligo	3.88e-05	6.89e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD80—vitiligo	3.88e-05	6.88e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD8A—vitiligo	3.84e-05	6.82e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD44—vitiligo	3.84e-05	6.81e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL2RA—vitiligo	3.83e-05	6.79e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD8A—vitiligo	3.83e-05	6.79e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD8A—vitiligo	3.78e-05	6.72e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD8A—vitiligo	3.76e-05	6.68e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CD80—vitiligo	3.75e-05	6.65e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL2RA—vitiligo	3.71e-05	6.59e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL2RA—vitiligo	3.69e-05	6.54e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD44—vitiligo	3.68e-05	6.53e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD80—vitiligo	3.68e-05	6.53e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CTLA4—vitiligo	3.63e-05	6.44e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR6—vitiligo	3.63e-05	6.44e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL2RA—vitiligo	3.63e-05	6.44e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD80—vitiligo	3.6e-05	6.39e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL2RA—vitiligo	3.55e-05	6.3e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL2RA—vitiligo	3.55e-05	6.3e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL2RA—vitiligo	3.54e-05	6.28e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR6—vitiligo	3.5e-05	6.2e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL2RA—vitiligo	3.46e-05	6.15e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD80—vitiligo	3.46e-05	6.15e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD80—vitiligo	3.46e-05	6.14e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL2RA—vitiligo	3.45e-05	6.12e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SH2B3—vitiligo	3.44e-05	6.1e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL2RA—vitiligo	3.42e-05	6.07e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—GZMB—vitiligo	3.42e-05	6.06e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL2RA—vitiligo	3.41e-05	6.05e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD44—vitiligo	3.4e-05	6.03e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL2RA—vitiligo	3.39e-05	6.02e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SH2B3—vitiligo	3.31e-05	5.88e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—GZMB—vitiligo	3.29e-05	5.84e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD8A—vitiligo	3.27e-05	5.8e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CD80—vitiligo	3.24e-05	5.75e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL2RA—vitiligo	3.23e-05	5.72e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CD80—vitiligo	3.19e-05	5.67e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD8A—vitiligo	3.15e-05	5.59e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR6—vitiligo	3.09e-05	5.49e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CD80—vitiligo	3.08e-05	5.46e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2RA—vitiligo	3.05e-05	5.41e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD80—vitiligo	3.03e-05	5.37e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2RA—vitiligo	3e-05	5.33e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CD80—vitiligo	2.96e-05	5.26e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CD80—vitiligo	2.96e-05	5.26e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD80—vitiligo	2.95e-05	5.24e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2RA—vitiligo	2.95e-05	5.23e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SH2B3—vitiligo	2.93e-05	5.21e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GZMB—vitiligo	2.92e-05	5.17e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD80—vitiligo	2.89e-05	5.13e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD80—vitiligo	2.88e-05	5.11e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CD80—vitiligo	2.86e-05	5.07e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2RA—vitiligo	2.85e-05	5.06e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD80—vitiligo	2.85e-05	5.05e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2RA—vitiligo	2.84e-05	5.04e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD80—vitiligo	2.83e-05	5.03e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD80—vitiligo	2.79e-05	4.96e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD8A—vitiligo	2.79e-05	4.95e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD80—vitiligo	2.73e-05	4.84e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2RA—vitiligo	2.68e-05	4.76e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD80—vitiligo	2.63e-05	4.66e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD80—vitiligo	2.61e-05	4.64e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CD80—vitiligo	2.54e-05	4.51e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2RA—vitiligo	2.51e-05	4.46e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CD80—vitiligo	2.51e-05	4.45e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD80—vitiligo	2.46e-05	4.36e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CD80—vitiligo	2.38e-05	4.22e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD80—vitiligo	2.37e-05	4.21e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2RA—vitiligo	2.34e-05	4.16e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2RA—vitiligo	2.29e-05	4.06e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD80—vitiligo	2.27e-05	4.03e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2RA—vitiligo	2.24e-05	3.98e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CD80—vitiligo	2.24e-05	3.97e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2RA—vitiligo	2.21e-05	3.91e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2RA—vitiligo	2.19e-05	3.89e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD80—vitiligo	2.19e-05	3.88e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD80—vitiligo	2.1e-05	3.72e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTT1—vitiligo	2.03e-05	3.6e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CD80—vitiligo	1.96e-05	3.47e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD80—vitiligo	1.94e-05	3.44e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CD80—vitiligo	1.91e-05	3.39e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2RA—vitiligo	1.91e-05	3.38e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CD80—vitiligo	1.87e-05	3.32e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CD80—vitiligo	1.84e-05	3.27e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2RA—vitiligo	1.84e-05	3.26e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CD80—vitiligo	1.83e-05	3.25e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CD44—vitiligo	1.68e-05	2.99e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2RA—vitiligo	1.63e-05	2.88e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CD80—vitiligo	1.59e-05	2.82e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CD80—vitiligo	1.53e-05	2.72e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—vitiligo	1.37e-05	2.42e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CD80—vitiligo	1.36e-05	2.41e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTM1—vitiligo	1.29e-05	2.29e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTT1—vitiligo	1.25e-05	2.21e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CD44—vitiligo	1.04e-05	1.84e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—vitiligo	8.42e-06	1.49e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—vitiligo	7.95e-06	1.41e-05	CbGpPWpGaD
